Dystrophin-deficient cardiomyocytes derived from human urine: New biologic reagents for drug discovery

Stem Cell Research

Volumn 12, Issue 2, 2014, Pages 467-480

  Guan, Xuan ^a,e   Mack, David L ^e,f   Moreno, Claudia M ^f   Strande, Jennifer L ^d   Mathieu, Julie ^e,f   Shi, Yingai ^b,c   Markert, Chad D ^b   Wang, Zejing ^h   Liu, Guihua ^b   Lawlor, Michael W ^d   Moorefield, Emily C ^b   Jones, Tara N ^b   Fugate, James A ^f   Furth, Mark E ^b   Murry, Charles E ^f,g   Ruohola Baker, Hannele ^e,f   Zhang, Yuanyuan ^b   Santana, Luis F ^f   Childers, Martin K ^e,f  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c JILIN UNIVERSITY   (China)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g University of Washington   (United States)

^h Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTININ; BIOLOGIC REAGENT; DYSTROPHIN; KRUPPEL LIKE FACTOR 4; MYC PROTEIN; MYOSIN HEAVY CHAIN ALPHA; MYOSIN HEAVY CHAIN BETA; OCTAMER TRANSCRIPTION FACTOR 4; REAGENT; TELOMERASE; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG; KRUPPEL LIKE FACTOR; MYC PROTEIN, HUMAN;

ADULT STEM CELL; ARTICLE; CASE REPORT; CELL DIFFERENTIATION; CELL METABOLISM; CELL SIZE; CELL STRUCTURE; CLONE; CONTROLLED STUDY; DRUG DEVELOPMENT; DUCHENNE MUSCULAR DYSTROPHY; ENZYME ACTIVITY; FIBROBLAST; HEART MUSCLE CELL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MALE; MONOLAYER CULTURE; MUTATION; NUCLEAR REPROGRAMMING; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TERATOMA; UPREGULATION; URINALYSIS; URINE; URINE DERIVED STEM CELL; ADULT; ANIMAL; BIOSYNTHESIS; CASE CONTROL STUDY; CELL CULTURE; CYTOLOGY; DEFICIENCY; FEMALE; METABOLISM; MOUSE; NONOBESE DIABETIC MOUSE; PATHOLOGY; PHYSIOLOGY; SCID MOUSE; YOUNG ADULT; CELL ISOLATION; PROTEIN DEFICIENCY;

ADULT; ANIMALS; CASE-CONTROL STUDIES; CELL DIFFERENTIATION; CELLS, CULTURED; DRUG DISCOVERY; DYSTROPHIN; FEMALE; HUMANS; INDUCED PLURIPOTENT STEM CELLS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MALE; MICE; MICE, INBRED NOD; MICE, SCID; MUSCULAR DYSTROPHY, DUCHENNE; MYOCYTES, CARDIAC; PROTO-ONCOGENE PROTEINS C-MYC; TELOMERASE; YOUNG ADULT;

EID: 84892470978     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2013.12.004     Document Type: Article

References (36)

1. Aasen T., Raya A., Barrero M.J., Garreta E., Consiglio A., Gonzalez F., Izpisua Belmonte J.C. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat. Biotechnol. 2008, 26(11):1276-1284. (doi: nbt.1503 [pii]). 10.1038/nbt.1503.
2. Adams J.E., Bodor G.S., Davila-Roman V.G., Delmez J.A., Apple F.S., Ladenson J.H., Jaffe A.S. Cardiac troponin I. A marker with high specificity for cardiac injury. [Comparative Study Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.]. Circulation 1993, 88(1):101-106.
3. Allen D.G., Zhang B.T., Whitehead N.P. Stretch-induced membrane damage in muscle: comparison of wild-type and mdx mice. [Research Support, Non-U.S. Gov't Review]. Adv. Exp. Med. Biol. 2010, 682:297-313. 10.1007/978-1-4419-6366-6_17.
4. Arenja N., Reichlin T., Drexler B., Oshima S., Denhaerynck K., Haaf P., Mueller C. Sensitive cardiac troponin in the diagnosis and risk stratification of acute heart failure. [Comparative Study]. J. Intern. Med. 2012, 271(6):598-607. 10.1111/j.1365-2796.2011.02469.x.
5. Bharadwaj S., Liu G., Shi Y., Markert C., Andersson K.E., Atala A., Zhang Y. Characterization of urine-derived stem cells obtained from upper urinary tract for use in cell-based urological tissue engineering. Tissue Eng. A 2011, 17(15-16):2123-2132. 10.1089/ten.TEA.2010.0637.
6. Chan E.M., Ratanasirintrawoot S., Park I.H., Manos P.D., Loh Y.H., Huo H., Schlaeger T.M. Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells. Nat. Biotechnol. 2009, 27(11):1033-1037. (nbt.1580 [pii]). 10.1038/nbt.1580.
7. Childers M.K., Okamura C.S., Bogan D.J., Bogan J.R., Sullivan M.J., Kornegay J.N. Myofiber injury and regeneration in a canine homologue of Duchenne muscular dystrophy. Am. J. Phys. Med. Rehabil. 2001, 80(3):175-181.
8. Childers M.K., Okamura C.S., Bogan D.J., Bogan J.R., Petroski G.F., McDonald K., Kornegay J.N. Eccentric contraction injury in dystrophic canine muscle. Arch. Phys. Med. Rehabil. 2002, 83(11):1572-1578. (S000399930200254X [pii]).
9. Childers M.K., Staley J.T., Kornegay J.N., McDonald K.S. Skinned single fibers from normal and dystrophin-deficient dogs incur comparable stretch-induced force deficits. Muscle Nerve 2005, 31(6):768-771. 10.1002/mus.20298.
10. Crisp A., Yin H., Goyenvalle A., Betts C., Moulton H.M., Seow Y., Wood M.J. Diaphragm rescue alone prevents heart dysfunction in dystrophic mice. [Research Support, Non-U.S. Gov't]. Hum. Mol. Genet. 2011, 20(3):413-421. 10.1093/hmg/ddq477.
11. De Pooter J., Vandeweghe J., Vonck A., Loth P., Geraedts J. Elevated troponin T levels in a female carrier of Duchenne muscular dystrophy with normal coronary angiogram: a case report and review of the literature. [Case Reports Review]. Acta Cardiol. 2012, 67(2):253-256.
12. Deconinck N., Dan B. Pathophysiology of duchenne muscular dystrophy: current hypotheses. [Review]. Pediatr. Neurol. 2007, 36(1):1-7. 10.1016/j.pediatrneurol.2006.09.016.
13. Dick E., Kalra S., Anderson D., George V., Ritso M., Laval S.H., Denning C. Exon skipping and gene transfer restore dystrophin expression in human induced pluripotent stem cells-cardiomyocytes harboring DMD mutations. Stem Cells Dev. 2013, 10.1089/scd.2013.0135.
14. Dorrenhaus A., Muller J.I., Golka K., Jedrusik P., Schulze H., Follmann W. Cultures of exfoliated epithelial cells from different locations of the human urinary tract and the renal tubular system. Arch. Toxicol. 2000, 74(10):618-626.
15. Grounds M.D. Two-tiered hypotheses for Duchenne muscular dystrophy. [Review]. Cell. Mol. Life Sci. 2008, 65(11):1621-1625. 10.1007/s00018-008-7574-8.
16. Hell J.W., Westenbroek R.E., Warner C., Ahlijanian M.K., Prystay W., Gilbert M.M., Catterall W.A. Identification and differential subcellular localization of the neuronal class C and class D L-type calcium channel alpha 1 subunits. [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.]. J. Cell Biol. 1993, 123(4):949-962.
17. Hoogerwaard E.M., Schouten Y., van der Kooi A.J., Gorgels J.P., de Visser M., Sanders G.T. Troponin T and troponin I in carriers of Duchenne and Becker muscular dystrophy with cardiac involvement. Clin. Chem. 2001, 47(5):962-963.
18. Judge D.P., Kass D.A., Thompson W.R., Wagner K.R. Pathophysiology and therapy of cardiac dysfunction in Duchenne muscular dystrophy. [Research Support, Non-U.S. Gov't Review]. Am. J. Cardiovasc. Drugs 2011, 11(5):287-294. 10.2165/11594070-000000000-00000.
19. Laflamme M.A., Chen K.Y., Naumova A.V., Muskheli V., Fugate J.A., Dupras S.K., Murry C.E. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat. Biotechnol. 2007, 25(9):1015-1024. (nbt1327 [pii][doi].). 10.1038/nbt1327.
20. Liu H., Ye Z., Kim Y., Sharkis S., Jang Y.Y. Generation of endoderm-derived human induced pluripotent stem cells from primary hepatocytes. Hepatology 2010, 51(5):1810-1819. 10.1002/hep.23626.
21. Mangiacapra F., Peace A.J., Di Serafino L., Pyxaras S.A., Bartunek J., Wyffels E., Barbato E. Intracoronary enalaprilat to reduce microvascular damage during percutaneous coronary intervention (ProMicro) study. [Randomized controlled trial]. J. Am. Coll. Cardiol. 2013, 61(6):615-621. 10.1016/j.jacc.2012.11.025.
22. Musch M.W., Davis-Amaral E.M., Vandenburgh H.H., Goldstein L. Hypotonicity stimulates translocation of ICln in neonatal rat cardiac myocytes. Pflugers Arch. 1998, 436(3):415-422.
23. Park I.-H., Zhao R., West J.A., Yabuuchi A., Huo H., Ince T.A., Daley G.Q. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008, 451(7175):141-146. [http://dx.doi.org/10.1038/nature06534], (http://www.nature.com/nature/journal/v451/n7175/suppinfo/nature06534_S1.html).
24. Park I.H., Lerou P.H., Zhao R., Huo H., Daley G.Q. Generation of human-induced pluripotent stem cells. Nat. Protoc. 2008, 3(7):1180-1186. (nprot.2008.92 [pii][doi]). 10.1038/nprot.2008.92.
25. Phillips M.F., Quinlivan R. Calcium antagonists for Duchenne muscular dystrophy. [Review]. Cochrane Database Syst. Rev. 2008, 4. (CD004571.). 10.1002/14651858.CD004571.pub2.
26. Pravdic D., Sedlic F., Mio Y., Vladic N., Bienengraeber M., Bosnjak Z.J. Anesthetic-induced preconditioning delays opening of mitochondrial permeability transition pore via protein Kinase C-epsilon-mediated pathway. [In Vitro Research Support, N.I.H., Extramural]. Anesthesiology 2009, 111(2):267-274. 10.1097/ALN.0b013e3181a91957.
27. Ramaciotti C., Iannaccone S.T., Scott W.A. Myocardial cell damage in Duchenne muscular dystrophy. [Case Reports Research Support, U.S. Gov't, P.H.S.]. Pediatr. Cardiol. 2003, 24(5):503-506. 10.1007/s00246-002-0408-9.
28. Ritner C., Bernstein H.S. Fate mapping of human embryonic stem cells by teratoma formation. J. Vis. Exp. 2010, 42:e2036. 10.3791/2036.
29. Shi Y., Liu G., Shantaram B., Atala A., Zhang Y. Urine derived stem cells with high telomerase activity for cell based therapy in urology. [Abstract]. J. Urol. 2012, 187(4, Supplement). (1.). 10.1016/j.juro.2012.02.821.
30. Townsend D., Turner I., Yasuda S., Martindale J., Davis J., Shillingford M., Metzger J.M. Chronic administration of membrane sealant prevents severe cardiac injury and ventricular dilatation in dystrophic dogs. J. Clin. Invest. 2010, 120(4):1140-1150. (41329 [pii]). 10.1172/JCI41329.
31. Wang Z., Storb R., Halbert C.L., Banks G.B., Butts T.M., Finn E.E., Tapscott S.J. Successful regional delivery and long-term expression of a dystrophin gene in canine muscular dystrophy: a preclinical model for human therapies. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't]. Mol. Ther. 2012, 20(8):1501-1507. 10.1038/mt.2012.111.
32. Warlich E., Kuehle J., Cantz T., Brugman M.H., Maetzig T., Galla M., Schambach A. Lentiviral vector design and imaging approaches to visualize the early stages of cellular reprogramming. Mol. Ther. 2011, 19(4):782-789. (mt2010314 [pii]). 10.1038/mt.2010.314.
33. Wasala N.B., Bostick B., Yue Y., Duan D. Exclusive skeletal muscle correction does not modulate dystrophic heart disease in the aged mdx model of Duchenne cardiomyopathy. Hum. Mol. Genet. 2013, 10.1093/hmg/ddt112.
34. Zhang Y., McNeill E., Tian H., Soker S., Andersson K.E., Yoo J.J., Atala A. Urine derived cells are a potential source for urological tissue reconstruction. J. Urol. 2008, 180(5):2226-2233. (S0022-5347(08)01820-X [pii]). 10.1016/j.juro.2008.07.023.
35. Zhou T., Benda C., Duzinger S., Huang Y., Li X., Li Y., Esteban M.A. Generation of induced pluripotent stem cells from urine. J. Am. Soc. Nephrol. 2011, 22(7):1221-1228. (ASN.2011010106 [pii]). 10.1681/ASN.2011010106.
36. Zhou T., Benda C., Dunzinger S., Huang Y., Ho J.C., Yang J., Esteban M.A. Generation of human induced pluripotent stem cells from urine samples. Nat. Protoc. 2012, 7(12):2080-2089. 10.1038/nprot.2012.115.